Epigenetic Regulation of Nutrient Transporters in Rheumatoid Arthritis Fibroblast‐like Synoviocytes is a dataset published in Arthritis & Rheumatology (2022). On theSindex it has a DataRank of 0.945, placing it in the top 21.4% of the data-sharing corpus. It has been cited 36 times, with 24 citing works in its 1-hop citation network.
Ranks in the top 21% for downstream scientific impact
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.542
From this paper's citation signal
Citation Network Contribution
0.403
From 21 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 24 citers.
European Molecular Biology Organization
Grant: ALTF‐960‐2018
National Institutes of Health
Grant: K01AR077111
National Institutes of Health
Grant: NS047101
National Institutes of Health
Grant: NS087611
National Institutes of Health
Grant: P30AR073761
National Institutes of Health
Grant: R01AR073324
National Institutes of Health
Grant: T32AR064194
National Institutes of Health
Grant: 5R01AR073324-02
Targeting hexokinase-2 in rheumatoid arthritis
National Institutes of Health
Grant: 5P30AR073761-04
Resource-based Center for the study of the joint microenvironment in rheumatology (Overall Application)
National Institutes of Health
Grant: 5T32AR064194-03
Rheumatic Diseases Research Training Grant
National Institutes of Health
Grant: 5K01AR077111-04
Role of choline metabolism in activated macrophage phenotypes
FWCI
5.68
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Additional file 5 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 4 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 1 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 2 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 3 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 2 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 1 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 6 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 6 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 5 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 3 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis
Additional file 4 of Dual inhibition of glycolysis and glutaminolysis for synergistic therapy of rheumatoid arthritis